OncoMatch/Clinical Trials/Osteosarcoma
Osteosarcoma Clinical Trials
OncoMatch filters Osteosarcoma trials by the molecular markers that determine eligibility — TP53, RB1, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaTop recruiting Osteosarcoma trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Children's Oncology Group
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
National Cancer Institute (NCI)
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Use of GnRHa During Chemotherapy for Fertility Protection
Kenny Rodriguez-Wallberg
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
N.N. Petrov National Medical Research Center of Oncology
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
How OncoMatch finds Osteosarcoma trials for you
AI reads the protocol
Every Osteosarcoma trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Osteosarcoma and mark your biomarker results — TP53, RB1 — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.